0001782250-19-000003.txt : 20190715 0001782250-19-000003.hdr.sgml : 20190715 20190715114158 ACCESSION NUMBER: 0001782250-19-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190715 DATE AS OF CHANGE: 20190715 EFFECTIVENESS DATE: 20190715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lucy Therapeutics, Inc. CENTRAL INDEX KEY: 0001782250 IRS NUMBER: 822363951 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-344266 FILM NUMBER: 19954544 BUSINESS ADDRESS: STREET 1: 501 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-249-4812 MAIL ADDRESS: STREET 1: 501 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001782250 Lucy Therapeutics, Inc. 501 Massachusetts Avenue Cambridge MA MASSACHUSETTS 02139 617-249-4812 DELAWARE None None Corporation true 2017 Amy Ripka 501 Massachusetts Avenue Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Ann DeWitt 501 Massachusetts Avenue Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b false 2019-06-28 false true false 0 3500000 2914590 585410 false 3 0 0 0 false Lucy Therapeutics, Inc. /s/ Amy Ripka Amy Ripka President 2019-07-15